The uptick in Concord Biotech share price came after the company was granted final approval from the USFDA for marketing its ...

Biotech company Colossal Biosciences said it has brought back the dire wolf, an animal that went extinct 10,000 years ago, ...

Colossal Biosciences said it brought back the dire wolf, which has been extinct for over 12,000 years. Here's how they said ...

Colossal Biosciences said it used ancient DNA from the extinct species to create three dire wolf pups named Romulus, Remus ...

Scientists from the Dallas-based biotech company Colossal Biosciences have brought three dire wolf pups into the world, ...

The biopharmaceutical company has announced the receipt of final approval from the United States Food and Drug Administration (USFDA) for marketing its Teriflunomide Tablets in various strengths.

XOMA's preferred shares (XOMAO, XOMAP) offer secure, attractive yields backed by biotech royalties, FDA-approved assets, and ...

Colossal Biosciences says it used novel gene-editing technology to alter gray wolf DNA to breed the animals. Dire wolves ...

Congress should invest at least $15 billion to support biotech research over the next five years and take other steps to ...

Omega Funds founder and managing director Otello Stampacchia isn’t afraid to tell it like he sees it.

A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid ...